Cargando…
Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania
BACKGROUND: Rabies vaccination of wildlife carnivores is a powerful tool to prevent, control and eliminate rabies. The presence of neutralizing rabies antibodies in blood is considered a reliable indicator of adequate vaccination. The main purpose of the present study was to analyze the seroprevalen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981835/ https://www.ncbi.nlm.nih.gov/pubmed/33743780 http://dx.doi.org/10.1186/s13028-021-00577-z |
_version_ | 1783667595264655360 |
---|---|
author | Zienius, Dainius Mickutė, Janina Pautienius, Arnoldas Grigas, Juozas Stankevičius, Arunas Pridotkas, Gediminas Jacevičius, Eugenijus Kemeraitė, Jolita Jacevičienė, Ingrida |
author_facet | Zienius, Dainius Mickutė, Janina Pautienius, Arnoldas Grigas, Juozas Stankevičius, Arunas Pridotkas, Gediminas Jacevičius, Eugenijus Kemeraitė, Jolita Jacevičienė, Ingrida |
author_sort | Zienius, Dainius |
collection | PubMed |
description | BACKGROUND: Rabies vaccination of wildlife carnivores is a powerful tool to prevent, control and eliminate rabies. The presence of neutralizing rabies antibodies in blood is considered a reliable indicator of adequate vaccination. The main purpose of the present study was to analyze the seroprevalence of specific antibodies in target populations of Lithuanian red fox (RF) and raccoon dog (RD) during the oral rabies vaccination (ORV) campaigns during the 2010–2019 period. RESULTS: Over the ten-year period, 7,261 RF and 2,146 RD sera samples were collected post-mortem in field conditions and tested using a commercial standardized enzyme-linked immunosorbent assay (ELISA) kit in Lithuania. In the ORV spring and autumn vaccination periods, 31.8% (20.3–43.4 95% CI – 95% confidence interval) and 31.7% (21.2–42.1 95% CI) of RF, and 34.1% (22.5–45.7 95% CI) and 34.7% (22.7–46.7 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL—Equivalent Units per Millilitre). The seroprevalence analysis in adult/ juvenile animal subpopulations indicated that 34.9% (27.2–42.5 95% CI) and 29.2% (20.3–37.9 95% CI) of RF, and 35.6% (25.2–46.0 95% CI) and 30.6% (20.2–40.9 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL). Statistically strong determinate correlations (r) between the serological results (pos.%) in RF adult/juvenile animal subpopulations (r = 0.937) and between RF and RD positive seroconvert (pos.%) sera samples during the spring vaccinations (r = 0.864) were demonstrated. In different ORV periods, 14–29% of RF and 7–25% of RD sera samples were identified as ELISA-negative (seroconversion < 0.5 EU/mL), but with low (0.125 < 0.49 EU/mL) antibody (Abs) titres. CONCLUSIONS: The 2010–2019 ORV programme has been an effective tool in both RF and RD populations in Lithuania. The rabies-free status of Lithuania was self-declared in 2015 with only three rabies cases identified in buffer zones since then. The percentage of ELISA-positive serum samples (seroconversion ≥ 0.5 EU/mL) during the different periods of vaccination was similar in RF and RD populations—32% and 34% respectively. The identified seroconversion average of 21.5% in RF and 16% in RD sera samples were officially identified as ELISA-negative (seronversion < 0.5 EU/mL), but with low 0.125 < 0.49 EU/mL Abs titres. That low, but positive seroconversion participated in the formation of populations overall immune status and can influence the interpretation of oral vaccination efficacy. |
format | Online Article Text |
id | pubmed-7981835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79818352021-03-22 Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania Zienius, Dainius Mickutė, Janina Pautienius, Arnoldas Grigas, Juozas Stankevičius, Arunas Pridotkas, Gediminas Jacevičius, Eugenijus Kemeraitė, Jolita Jacevičienė, Ingrida Acta Vet Scand Research BACKGROUND: Rabies vaccination of wildlife carnivores is a powerful tool to prevent, control and eliminate rabies. The presence of neutralizing rabies antibodies in blood is considered a reliable indicator of adequate vaccination. The main purpose of the present study was to analyze the seroprevalence of specific antibodies in target populations of Lithuanian red fox (RF) and raccoon dog (RD) during the oral rabies vaccination (ORV) campaigns during the 2010–2019 period. RESULTS: Over the ten-year period, 7,261 RF and 2,146 RD sera samples were collected post-mortem in field conditions and tested using a commercial standardized enzyme-linked immunosorbent assay (ELISA) kit in Lithuania. In the ORV spring and autumn vaccination periods, 31.8% (20.3–43.4 95% CI – 95% confidence interval) and 31.7% (21.2–42.1 95% CI) of RF, and 34.1% (22.5–45.7 95% CI) and 34.7% (22.7–46.7 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL—Equivalent Units per Millilitre). The seroprevalence analysis in adult/ juvenile animal subpopulations indicated that 34.9% (27.2–42.5 95% CI) and 29.2% (20.3–37.9 95% CI) of RF, and 35.6% (25.2–46.0 95% CI) and 30.6% (20.2–40.9 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL). Statistically strong determinate correlations (r) between the serological results (pos.%) in RF adult/juvenile animal subpopulations (r = 0.937) and between RF and RD positive seroconvert (pos.%) sera samples during the spring vaccinations (r = 0.864) were demonstrated. In different ORV periods, 14–29% of RF and 7–25% of RD sera samples were identified as ELISA-negative (seroconversion < 0.5 EU/mL), but with low (0.125 < 0.49 EU/mL) antibody (Abs) titres. CONCLUSIONS: The 2010–2019 ORV programme has been an effective tool in both RF and RD populations in Lithuania. The rabies-free status of Lithuania was self-declared in 2015 with only three rabies cases identified in buffer zones since then. The percentage of ELISA-positive serum samples (seroconversion ≥ 0.5 EU/mL) during the different periods of vaccination was similar in RF and RD populations—32% and 34% respectively. The identified seroconversion average of 21.5% in RF and 16% in RD sera samples were officially identified as ELISA-negative (seronversion < 0.5 EU/mL), but with low 0.125 < 0.49 EU/mL Abs titres. That low, but positive seroconversion participated in the formation of populations overall immune status and can influence the interpretation of oral vaccination efficacy. BioMed Central 2021-03-20 /pmc/articles/PMC7981835/ /pubmed/33743780 http://dx.doi.org/10.1186/s13028-021-00577-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zienius, Dainius Mickutė, Janina Pautienius, Arnoldas Grigas, Juozas Stankevičius, Arunas Pridotkas, Gediminas Jacevičius, Eugenijus Kemeraitė, Jolita Jacevičienė, Ingrida Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title | Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title_full | Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title_fullStr | Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title_full_unstemmed | Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title_short | Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania |
title_sort | analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in lithuania |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981835/ https://www.ncbi.nlm.nih.gov/pubmed/33743780 http://dx.doi.org/10.1186/s13028-021-00577-z |
work_keys_str_mv | AT zieniusdainius analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT mickutejanina analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT pautieniusarnoldas analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT grigasjuozas analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT stankeviciusarunas analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT pridotkasgediminas analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT jaceviciuseugenijus analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT kemeraitejolita analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania AT jacevicieneingrida analysisofseroprevalenceintargetwildlifeduringtheoralrabiesvaccinationprogrammeinlithuania |